MedPath
TGA Approval

ABILIFY ASIMTUFII aripiprazole (as monohydrate) 960 mg/3.2 mL prolonged release suspension for injection pre-filled syringe (410039)

410039

ABILIFY ASIMTUFII aripiprazole (as monohydrate) 960 mg/3.2 mL prolonged release suspension for injection pre-filled syringe

Lundbeck Australia Pty Ltd

February 5, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/f713fc4797af46ed05e44992e472de3e.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/a93227e3848ab3ab9758837c58bbfd47.pdf

Active Ingredients

aripiprazole monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ABILIFY ASIMTUFII aripiprazole (as monohydrate) 960 mg/3.2 mL prolonged release suspension for injection pre-filled syringe (410039) - TGA 批准文号 | MedPath